Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001015820-23-000035
Filing Date
2023-08-10
Accepted
2023-08-09 21:40:55
Documents
2
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K a2023q2pr6-k.htm 6-K 430660
2 qiagen_logoa.jpg GRAPHIC 69764
  Complete submission text file 0001015820-23-000035.txt   527324
Mailing Address HULSTERWEG 82 PL VENLO P7 5912
Business Address HULSTERWEG 82 PL VENLO P7 5912 31-77-35566-00
QIAGEN N.V. (Filer) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38332 | Film No.: 231156956
SIC: 2836 Biological Products, (No Diagnostic Substances)